Jakub Hlávka, PhD, is a Research Assistant Professor in the Health Policy and Management Department of the Price School of Public Policy and Schaeffer Center for Health Policy & Economics, University of Southern California. His research interests include innovative payment for healthcare, health system reform, emerging therapies and the study of inequality. Dr. Hlávka joined the Center after completing his PhD at the Pardee RAND Graduate School where he studied innovative payment approaches for emerging treatments like cell and gene therapies, specializing in cardiovascular conditions. He has additional professional experience from Genentech where he assisted in R&D portfolio planning, and as a consultant to the Tufts Medical Center's Center for the Evaluation of Value and Risk in Health where he studied oncology-specific outcome measures. Aside from healthcare, he has co-authored studies in national security, aerospace and emerging technologies and has served in research and consulting roles at the intersection of intellectual property, national security and governance at the Fraunhofer Society in Germany, RAND Europe in Cambridge, England, and at the Czech Government and Ministry of Finance in Prague. Dr. Hlávka holds degrees from the Pardee RAND Graduate School, Georgetown University and the University of Economics in Prague.